Unilever
Unilever
<UNILEVER N.V.>
Rotterdam, Netherlands, Highlights
<UNA NA> “We believe that sustainable and equitable growth is the only way to
<Euronext Amsterdam> create long-term value for our stakeholders. That’s why we have
placed the Unilever Sustainable Living Plan at the heart of our
12-m rating business model.”
12m target price 52.07
Last Closing Price 47.74 Unilever N.V. manufactures and distributes food, beverages, home
as of May 31st and personal care products. It has business operations in 100
Upside Potential 9.1% countries and serves approximately 2.5 billion customers residing in
175 190 countries. It markets these products under 400 brands in both
domestic and international markets.
155
We issue a BUY recommendation with a target price of EUR 52.07
135
per share representing an upside of 9.1% from its May 31th, 2018
115
closing price of EUR 47.74.
Our recommendation lays on the following key investment highlights:
95 • A diversified business mix and product innovation, which allows
Unilever to fulfill the changing preferences' of customers.
75 • A strong growth in emerging markets specially for Home and
2013 2014 2015 2016 2017 Personal care segments.
Unilever N.V. DJEuro Stoxx 600 • Investment Risks: include business and operational, financial and
market risks that were assessed for impact and likelihood and
afterwards ranked in a risk matrix.
Trading Data and Key Metrics
• Robust financial outlook supported by M&A: Unilever had a strong
52-Week High/Low 52.31/42.13 year 2017 with sales growth to EUR 53,715 with a 1.90% increase
Market Cap. 139,997.6M and an increase in EBIT Margin of 1.6%..
Shares o/s 1,714.7M Recent News
Avg, Volume (mm) 4.739M • In May Unilever PLC and Unilever N.V. announce the beginning of
Beta (5Y) 0.92 a program to buy back shares with an aggregate market value of
Dividend Yield 3.06% up to €6 biillion.
Free Float 94.34% • Unilever completes acquisition of Quala”s beauty & personal and
EV / Sales 3.00 home care brands as for March 2018.
EV / EBITDA 15.20 • In February 2018, Unilever received a biding offer from Dr.Oetker
EV / EBIT 17.78 to acquire the Alsa baking and dessert preparation business.
P/E 22.12 • On February 5th, Unilever priced €2.0 billion bonds on European
markets
Lizette Navarro Key Ratios FY12 FY13 FY14 FY15 FY16 FY17
Equity Research Analyst Revenue growth % 10.5% (3.0%) (2.7%) 10.0% (1.0%) 1.9%
Gross Profit % 12.2% (0.3%) (3.3%) 12.0% 0.1% 3.0%
EBIT % 13.0% 15% 16% 14% 15% 16%
Net Profit % 8.5% 9.7% 10.7% 9.2% 9.8% 11.3%
Philipp Utz ROIC - 7% 7% 5% 5% 6%
Foto Equity Research Analyst ROE % - 31% 36% 32% 31% 39%
ND / EBITDA (x) 0.9x 1.0x 1.1x 1.3x 1.4x 2.0x
Interest Coverage (x) 13.0x 15x 16x 14x 15x 16x
Earnings per share EUR 1.54 1.71 1.82 1.73 1.83 2.16
Dima Solovei Payout Ratio % 61.8% 61.8% 61.7% 67.9% 69.6% 64.7%
Equity Research Analyst Dividend Yield % 3.3% 3.6% 3.4% 2.9% 3.2% 3.0%
Revenue / Employee 296,671 286,190 279,977 315,366 311,911 325,545
0
Equity Research 14.06.2018 <Consumer Goods>
Business Description
Revenue per Segment 2017
18%
Unilever is a dual listed company consisting of Unilever plc based in
London and Unilever N.V., based in Rotterdam. It operates in the
39% Fast Moving Consumer Goods (FMCG) Industry making and selling
around 400 brands in more than 190 countries, giving Unilever a
unique position in emerging markets which generates 58% of the
23% turnover. Unilever operates and manages 306 factories in 69
countries and maintains a network of approximately 400 warehouses
20% in various global markets. Unilever operates through a network of
Home Care Personal Care distribution centers, group-operated facilities, satellite warehouses,
Foods Refreshments public storage depots, wholesalers, independent grocery stores, co-
Source: Company Information, Team estimates operatives and various food service providers. The company
classifies its geographic operations into three regions: Asia, Africa,
Revenue by Geographical the Middle East, Turkey, Russia, Ukraine and Belarus
Regions 2017
24% (Asia/AMET/RUB), the Americas, and Europe. Unilever\s largest
international competitors are Nestlé and Procter & Gamble. It also
faces competition in local markets or specific product ranges from
43%
numerous companies, including Danone, Henkel, L’Oréal., Reckitt
Benckiser Gruoup, Beiersdorf, Kraft Heinz, The Coca-Cola
Company, PepsiCo, Colgate-Palmolive and General Mills.
33% Unilever is organized into four main divisions: the largest being
Asia/AMET/RUB The Americas Europe Personal Care (39% of Turnover), followed by Foods (23%), Home
Source: Company Information, Team estimates
Care (20%) and Refreshment (18%). As of January 1st, 2018 Foods
and Refreshment are combined into a single segment.
EBIT Margins by Segment
75,000 9%
65,000 Home Care
55,000 7%
45,000
Produces and sells powder, liquids and capsules, soap bars and a
4% wide range of cleaning products. Offers tailored products that include
35,000
25,000 2% soap bars for lower income category consumers and other
15,000
5,000 -1% household products including bleach, home water purifiers and
surface cleaners.
Home Care accounts for 20% of the company's turnover and 13% of
Total Revenues Personal Care operating profit. Its two major global brands with a turnover of €1
Home Care Foods
Refreshment billion are Dirt is Good, which includes Omo and Persil and Surf.
Source: Company Information, Team estimates Other well-known brands are Domestos, Sunlight, Cif, Pureit, the
water purification brand and Blueari, the air purification business.
The Home Care segment has been steadily growing for the past
eight years with the CAGR almost doubling between periods 2008-
13 and 2014-16. Year 2016 saw some impressive results, when the
growth rate reached 5% in the global market.
1
Equity Research 14.06.2018 <Consumer Goods>
Personal Care
40,000
Personal hygiene market consists of the retail sale of antiperspirants
20,000
and deodorants in spray, stick, roll-on, cream, gel, and solid formats.
Bath & shower, bubble-baths and bath time washing gels and lotions.
0 The segment also includes non-liquid products added to baths such
2012 2013 2014 2015 2016 2017 as bath bombs, beads, and salts. And soap, bar soaps and liquid
Personal Care Home Care soaps.
Foods Refreshment
The Personal Care segment is the largest category and accounts for
Source: Company Information, Team estimates 39% of Unilever’s turnover and 46% of operating profit. This segment
has leading global position in hair, skin cleansing and deodorants
Total Operating Profit (%) by and includes brands like Axe, Dove, Lux, Rexona and Sunsilk with a
Category
turnover of €1 billion. It also includes household names such as
100%
80%
TRESenmé, Signal, Lifebuoy and Vaseline. Its main markets are
60% US, India, Brazil and Indonesia.
40%
20% Refreshments (beverage and ice-cream)
0% Offers ice cream, tea-based beverages, weight management
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2
Equity Research 14.06.2018 <Consumer Goods>
India
Hong Kong
Thailand
South Korea
New Zealand
Pakistan
Taiwan
Malaysia
Singapore
China
Indonesia
Philippines
Australia
2009
2011
2013
2015
Home Care
Latin America is giving positive signals, as Brazil, the third largest
consumer in the world recovers from its severe recession,
urbanisation continues and concern for personal and family hygiene
increases. Previously stagnating region scaling up on home care
purchases, growth 13.1% in 2017.
3
Equity Research 14.06.2018 <Consumer Goods>
Jan 15
Jan 16
Jan 17
Jan 18
Jul 14
Jul 15
Jul 16
Jul 17
4
Equity Research 14.06.2018 <Consumer Goods>
5
Equity Research 14.06.2018 <Consumer Goods>
2019
2020
6
Equity Research 14.06.2018 <Consumer Goods>
Investment Summary
Industry & growth potential Business model
7
Equity Research 14.06.2018 <Consumer Goods>
Financial Analysis
Revenue (bn. €) Ratios & Key Indicators 2012 2013 2014 2015 2016 2017
56 15% In % of revenue
54 Revenue 51,324 49,797 48,436 53,272 52,713 53,715
10% 10%
52 Cost of materials % -41% -40% -41% -40% -40% -40%
50 5% EBITDA % 16% 17% 19% 16% 17% 19%
48 2% Staff costs % -12% -12% -12% -12% -12% -12%
-3% 0%
46 -1% D&A + impairm. Losses % 2% 2% 2% 3% 3% 3%
-3%
44 -5% EBIT % 13% 15% 16% 14% 15% 16%
2013 2014 2015 2016 2017 Tax rate in % of EBIT 25% 25% 27% 27% 25% 19%
8
Equity Research 14.06.2018 <Consumer Goods>
94 94 102 100
100 88 Buy low
Unilever uses its reputation to borrow money cheaply with an
53 52 50 52 49
50 average after tax cost of debt of 1.57%, which results in modest
21 21 20 22 23
liquidity KPIs, a negative working capital and a high leverage. In fact
0 Unilever increased its current financial liabilities by 2.8 billion Euros
2013 2014 2015 2016 2017 and its overall financial liabilities by almost 8 billion Euro in 2017,
mainly by issuing bonds. Besides increasing leverage this move
DIH DSO DPO helps Unilever to take advantage of the current low interest
Source: Company Information, Team estimates environment.
9
Equity Research 14.06.2018 <Consumer Goods>
Valuation
Price Equity Bridge Price Target: EUR 52.07 Recommendation: BUY
180,000 169,607 1000
160,000 145,630
800 The Valuation Price Target is derived using 5-Y DCF model as the
Dil.
140,000 -27,228+4,009 -758 Shares
600 main source of value, and 20-Y DDM and relative multiples valuation
120,000 2,814 400
calculated to justify our price target. The issued BUY
100,000 51,75
200 recommendation offers a 9.1% share price growth potential.
80,000 0
3.0% significantly faster than in the previous 5-Y period, as the company
continues enhancing its presence in high-profit high-margin sectors,
-0.5 2.0%
such as Personal Care, and generates much of their sales from the
1.0% of APAC market.
-2.5 0.0%
2013
2012
2014
2015
2016
2017
2018
2019
2020
2021
2022
D&A CAPEX
CAPEX Margin
Source: Company Information, Team estimates
10
Equity Research 14.06.2018 <Consumer Goods>
2024
2026
2028
2030
2032
2034
2036
Source: Company Information, Team estimates Relative Valuation – Trading Multiples (EV/EBITDA)
DPS, EPS, Payout Ratio The peer group is composed of international manufacturers and
distributors of Foods & Beverages, Home & Personal Care products,
2.4 72%
70% or both. The competitors were shortlisted based on their size (Large
2.0
68% Cap Stocks), business model, capital structure and EBITDA, leading
1.6 66% to the peer group of 12 companies. We used EV/EBITDA multiple,
1.2 64%
62% because we D&A costs do not significantly impact company Cash
0.8
60% Flows.
0.4 58%
0 56%
2012 2013 2014 2015 2016 2017
Enterprise Value / Price /
DPS - Common Stock a year LTM 2018E LTM 2018E LTM 2018E
Diluted EPS Share
Payout Ratio Revenue Revenue EBITDA EBITDA EPS EPS
Source: Company Information Unilever 3.2x 3.1x 17.0x 16.3x 34.0x 23.3x
Price Range LTM EV Nestlé S.A. 3.1x 3.0x 16.5x 13.5x 23.7x 21.8x
Danone SA 2.5x 2.4x 13.4x 11.8x 20.4x 18.4x
Henkel AG & Co. KGaA 2.4x 2.3x 13.5x 13.7x 19.0x 17.8x
P/E LTM
L'Oréal S.A. 4.0x 3.9x 17.2x 17.0x 27.6x 26.2x
EV/EBIT Y1 Reckitt Benckiser Group plc 5.5x 4.8x 17.0x 15.7x 21.2x 19.4x
EV/EBIT LTM
Beiersdorf Aktiengesellschaft 2.9x 2.8x 16.3x 14.6x 29.3x 27.4x
The Procter&Gamble Company 3.1x 3.8x 13.4x 12.5x 19.6x 22.0x
EV/EBITDA LTM
The Kraft Heinz Company 4.8x 4.7x 15.5x 13.5x 21.6x 20.0x
EV/Rev Y1 The Coca-Cola Company 6.2x 6.6x 20.0x 18.5x 21.7x 20.1x
PepsiCo, Inc. 2.5x 2.5x 13.3x 11.6x 18.7x 17.2x
EV/Rev LTM
Colgate-Palmolive Company 3.9x 3.7x 13.5x 12.5x 21.7x 19.7x
$30 $40 $50 $60 $70 $80 General Mills, Inc. 2.3x 2.2x 13.0x 13.8x 14.0x 13.9x
Source: Thomas Reuters
11
Equity Research 14.06.2018 <Consumer Goods>
Medium
MK1
brand and reputation.
Mitigation: Guidelines are follow according the Code of Business
OP1 OP2 Principles and the Code Policies with regards to the behavior of all
Low
12
Equity Research 14.06.2018
Balance Sheet
Balance Sheet
ASSETS 2012 2013 2014 2015 2016 2017
Cash And Equivalents 2,465.0 2,285.0 2,151.0 2,302.0 3,382.0 3,317.0
Short Term Investments 711.0 934.0 599.0 596.0 565.0 521.0
Trading Asset Securities 56.0 20.0 21.0 124.0 181.0 171.0
Total Cash & ST Investments 3,232.0 3,239.0 2,771.0 3,022.0 4,128.0 4,009.0
Accounts Receivable 2,793.0 2,852.0 2,827.0 2,917.0 3,329.0 3,439.0
Other Receivables 217.0 217.0 281.0 230.0 1,190.0 1,538.0
Notes Receivable 2.0 100.0 180.0 269.0 208.0 277.0
Total Receivables 3,012.0 3,169.0 3,288.0 3,416.0 4,727.0 5,254.0
Inventory 4,436.0 3,937.0 4,168.0 4,335.0 4,278.0 3,962.0
Prepaid Exp. 549.0 516.0 540.0 561.0 504.0 452.0
Other Current Assets 918.0 1,261.0 1,580.0 1,352.0 247.0 3,306.0
Total Current Assets 12,147.0 12,122.0 12,347.0 12,686.0 13,884.0 16,983.0
Gross Property, Plant & Equipment 17,509.0 17,229.0 18,914.0 19,917.0 21,207.0 19,398.0
13
Equity Research 14.06.2018
14
Equity Research 14.06.2018
Income Statement
Income Statement
2012 2013 2014 2015 2016 2017
Revenue 51,324.0 49,797.0 48,436.0 53,272.0 52,713.0 53,715.0
Total Revenue 51,324.0 49,797.0 48,436.0 53,272.0 52,713.0 53,715.0
Cost Of Goods Sold 30,530.0 29,065.0 28,387.0 30,808.0 30,229.0 30,547.0
Gross Profit 20,794.0 20,732.0 20,049.0 22,464.0 22,484.0 23,168.0
Selling General & Admin Exp. 12,959.0 12,308.0 11,208.0 14,065.0 13,799.0 13,507.0
R & D Exp. 1,003.0 1,040.0 955.0 1,005.0 978.0 900.0
Other Operating Exp., Total 13,962.0 13,348.0 12,163.0 15,070.0 14,777.0 14,407.0
Operating Income 6,832.0 7,384.0 7,886.0 7,394.0 7,707.0 8,761.0
Interest Expense (524.0) (497.0) (486.0) (552.0) (572.0) (608.0)
Interest and Invest. Income 136.0 117.0 162.0 235.0 219.0 175.0
Net Interest Exp. (388.0) (380.0) (324.0) (317.0) (353.0) (433.0)
Income/(Loss) from Affiliates 105.0 113.0 98.0 107.0 127.0 155.0
Currency Exchange Gains (Loss) (2.0) (3.0) (14.0) 36.0 (12.0) 13.0
Other Non-Operating Inc. (Exp.) - - - - - (26.0)
EBT Excl. Unusual Items 6,547.0 7,114.0 7,646.0 7,220.0 7,469.0 8,470.0
Gain (Loss) On Sale Of Invest. (14.0) - - - - -
Legal Settlements - - - - - 65.0
Other Unusual Items - - - - - (382.0)
EBT Incl. Unusual Items 6,533.0 7,114.0 7,646.0 7,220.0 7,469.0 8,153.0
Income Tax Expense 1,697.0 1,851.0 2,131.0 1,961.0 1,922.0 1,667.0
Net Income to Company 4,836.0 5,263.0 5,515.0 5,259.0 5,547.0 6,486.0
Minority Int. in Earnings (468.0) (421.0) (344.0) (350.0) (363.0) (433.0)
Net Income 4,368.0 4,842.0 5,171.0 4,909.0 5,184.0 6,053.0
15
Equity Research 14.06.2018 <Consumer Goods>
SHAREHOLDERS
DIRECTORS
1 UN = 1 ULVR
1 UN = 1 UNA
TICKER: UN TICKER: UL
TRADED: NYSE 1 UN = 1 UL TRADED: NYSE
16
Equity Research 14.06.2018
Mr. Graeme Pitkethly has been the Chief Financial Officer of the company since October
2015. He was appointed as a Director of the company in April 2016. Previously, Mr.
Pitkethly held several leadership roles including Executive Vice President and Chairman
for Unilever UK and Ireland, Senior Vice President of Finance for Global Markets, Global
Head of Mergers and Acquisitions, Head of Treasury, Pensions and Tax, and Chief
Financial Officer of Unilever Indonesia. Prior to joining the company, he held several
senior corporate finance roles at PricewaterhouseCoopers and in the
telecommunications industry.
Mr. Paul Polman has been the Chief Executive Officer and Director of the company
since January 2009. He was appointed as an Executive Director of the company in
October 2008. Prior to this, Mr. Polman served as the Chief Financial Officer of Nestle
S.A. from January 2006 and as the Executive Vice President for the Americas from
February 2008. He began his career at Procter & Gamble in 1979 and served as Group
President Europe and Officer until 2001. He also serves as a Director of The Consumer
Goods Forum.
David Blanchard Senior Management Chief Research and Development Officer 2014
Mr. David Blanchard has been the Chief Research and Development Officer of the
company since April 2014. Previously, he served as the Chief Category Research and
Development Officer of the company since January 2013. Mr. Blanchard joined the
company in 1986 as the Development Manager of Spreads and held several senior
managerial positions including Senior Vice President of Unilever Research and
Development, Senior Vice President of Marketing Operations Foods Americas, Vice
President of Research and Development for Global Dressing and the Chairman of
Unilever Canada Inc.
17
Equity Research 14.06.2018
Mr. Marc Engel has been the Chief Supply Chain Officer of the company since January
2016. Previously, he held several leadership roles at the company, including the
Executive Vice President of Unilever East Africa and Emerging Markets; Chief
Procurement Officer and Vice President for Supply Chain, Spreads, Dressings and Olive
Oil Europe at Unilever Supply Chain Company. Mr. Engel also served as the Operations
Manager for Birds Eye Wall’s at Unilever UK; and Unilever Meat Group NL.
Ms. Ritva Sotamaa has been the Chief Legal Officer of the company since February
2013. Previously, she served as the General Counsel for Siemens AG – Siemens
Healthcare. Ms. Sotamaa also held several managerial roles at General Electric
Company including General Counsel, GE Healthcare Systems and General Counsel at
Instrumentarium Corporation.
Mr. Marijn Dekkers has been the Non-Executive Chairman of the company since April
2016. Previously, he served as Chief Executive Officer at Bayer AG and Thermo Fisher
Scientific Inc. Currently, Mr. Dekkers serves as the Non Executive Director at General
Electric.
Mr. Keith Weed has been the Chief Marketing and Communications Officer of the
company since April 2010. He joined the company in 1983 and held various managerial
positions such as Executive Vice President for Global Home Care and Hygiene and the
Chairman of Lever Faberg
18
Equity Research 14.06.2018
Porter’s Five Forces Buyers Power: buyers are all around the world;
they have no power to bring the prices down. But it
is easier for the customer to switch to a competitor
Buyer
Power if they don’t are satisfied in every level weather it is
5 about the price of quality of the product.
4
Competitor Rivalry: There are not only small or
3 reginal shops but also big giants like P&G, Kraft
2 Barriers and Nestle. These big industries have the power to
Rivalry
1
to entry persuade the customer by introducing the equally
attractive and best performer products. Low
0 switching cost allow customer to switch to other
brands easily.
19
Equity Research 14.06.2018
Strengths Weaknesses
• Global presences – sales +190 countries • Dependence on Distribution and Retailers –
• Brand product mix – strong popular brands lack of forward integration
• Focused R&D activities and integrated • High number of substitutes
supply chain • Limited business diversification
• Economies of scale
• Evolving Portfolio and Developing Channels
SWOT
Opportunities Threats
• Potential in Emerging Markets
• Growing Demand for Premium and • Global and regional Competitors
Specialized High-End products in Skin Care • Private label brands from Retailers
Segment • Product imitation
• Social Media for advertising • An increase of social ethic and concern for
the environment among customers
• Stricter regulations
20
Equity Research 14.06.2018
Revenue Growth
Company Name 31.12.2013 31.12.2014 31.12.2015 31.12.2016 31.12.2017 31.12.2018 31.12.2019 31.12.2020 31.12.2021
PepsiCo Inc -2.48% 13.32% 4.92% 3.95% -11.35% 5.42% 3.22% 1.94% 1.55%
Colgate-Palmolive Co -2.13% 12.69% 3.38% -2.10% -10.87% 7.26% 3.07% 2.92% 4.42%
General Mills Inc -4.44% 22.15% -7.13% -6.27% 0.00% -4.22% 6.70% 2.21% 1.66%
Kraft Heinz Co 0.00% 97.55% 88.26% 49.18% -13.21% 1.99% 1.33% 1.63% 2.66%
Coca-Cola Co -6.33% 11.55% 7.26% -2.37% -25.87% -8.05% 3.82% 3.90% 4.65%
Nestle SA 1.11% 1.44% 7.12% 2.46% -8.12% 3.58% 4.57% 2.52% 5.02%
Danone SA 2.06% -0.72% 6.00% -2.09% 12.45% 1.47% 4.18% 4.23% 6.41%
Henkel AG & Co KgaA -0.94% 0.45% 10.11% 3.46% 7.03% 1.14% 3.61% 3.64% 3.93%
L'Oreal SA -1.51% 1.84% 7.80% 2.58% 4.44% 1.47% 5.00% 4.95% 5.40%
Reckitt Benckiser Group PLC -5.28% 1.92% 5.87% -7.63% 16.57% 9.55% 3.49% 3.70% 8.37%
Beiersdorf AG 1.67% 2.34% 6.38% 0.99% 4.50% 2.01% 4.57% 4.50% 4.39%
Procter & Gamble Co -11.77% 16.92% -7.45% -3.15% 0.00% -0.07% 2.71% 3.25% 3.15%
Unilever NV -2.98% -2.73% 9.98% -1.05% 1.90% 2.00% 3.00% 3.00% 4.00%
Min -11.77% -0.72% -7.45% -7.63% -25.87% -8.05% 1.33% 1.63% 1.55%
0.25 -4.65% 1.74% 4.53% -2.56% -10.99% 0.84% 3.18% 2.44% 3.03%
Peer Group 4.93% 12.48% 2.87% 5.36% 16.12% 3.20% 1.39% 1.54% 2.09%
Median -1.82% 6.95% 6.19% -0.55% 0.00% 1.73% 3.72% 3.44% 4.40%
0.75 0.28% 14.22% 7.40% 2.80% 5.13% 4.04% 4.57% 3.98% 5.12%
Max 2.06% 97.55% 88.26% 49.18% 16.57% 9.55% 6.70% 4.95% 8.37%
Min 35.40% 34.70% 35.07% 36.08% 36.08% 34.08% 34.46% 34.70% 35.03%
0.25 48.13% 47.90% 48.90% 49.94% 48.32% 49.08% 49.49% 49.93% 50.21%
Peer Group 12.04% 12.00% 10.01% 10.37% 11.78% 11.08% 11.33% 11.47% 12.74%
Median 53.08% 53.64% 49.97% 52.99% 54.68% 52.34% 52.59% 53.27% 53.10%
0.75 60.17% 59.90% 58.91% 60.30% 60.11% 60.16% 60.82% 61.40% 62.95%
Max 71.30% 71.15% 71.19% 71.59% 71.72% 71.88% 72.05% 72.17% 72.43%
21
Equity Research 14.06.2018
EBIT Margin
Company Name 31.12.2013 31.12.2014 31.12.2015 31.12.2016 31.12.2017 31.12.2018 31.12.2019 31.12.2020 31.12.2021
PepsiCo Inc 15.22% 14.99% 15.74% 15.95% 16.98% 16.62% 17.04% 17.33%n/a
Colgate-Palmolive Co 23.65% 24.33% 24.82% 26.16% 25.31% 25.61% 26.40% 26.95% 26.18%
General Mills Inc 16.25% 16.05% 16.52% 17.96% 17.96% 16.70% 17.25% 17.74% 20.03%
Kraft Heinz Co 2.40% 14.36% 14.39% 27.12% 27.75% 26.32% 26.74% 26.88% 27.86%
Coca-Cola Co 23.99% 22.82% 23.04% 23.08% 26.76% 32.42% 33.68% 34.69% 40.22%
Nestle SA 16.44% 15.41% 15.60% 15.94% 16.48% 16.14% 16.81% 17.35% 17.07%
Danone SA 9.95% 10.14% 13.06% 13.75% 13.81% 15.05% 15.63% 16.17% 16.64%
Henkel AG & Co KgaA 15.53% 16.11% 16.10% 17.28% 17.45% 17.46% 17.84% 18.19% 17.65%
L'Oreal SA 16.92% 17.18% 17.88% 18.12% 17.95% 18.33% 18.58% 18.73% 18.74%
Reckitt Benckiser Group PLC 23.13% 24.73% 26.86% 27.81% 26.77% 26.77% 27.58% 27.90% 27.24%
Beiersdorf AG 13.68% 13.83% 14.34% 15.54% 15.53% 15.75% 16.17% 16.56% 16.78%
Procter & Gamble Co 18.70% 19.83% 21.99% 22.57% 22.57% 21.72% 22.07% 22.61%n/a
Unilever NV 14.83% 16.28% 13.88% 14.62% 16.31% 17.00% 18.00% 18.50% 19.50%
Min 2.40% 10.14% 13.06% 13.75% 13.81% 15.05% 15.63% 16.17% 16.64%
0.25 14.83% 14.84% 15.30% 15.95% 16.86% 16.50% 16.99% 17.35% 17.22%
Peer Group 4.97% 5.74% 6.96% 7.90% 8.81% 9.29% 9.50% 9.55% 9.76%
Median 16.35% 16.08% 16.31% 18.04% 17.96% 17.89% 18.21% 18.46% 19.38%
0.75 19.80% 20.58% 22.25% 23.85% 25.67% 25.79% 26.48% 26.90% 26.97%
Max 23.99% 24.73% 26.86% 27.81% 27.75% 32.42% 33.68% 34.69% 40.22%
EBITDA Margin
Company Name 31.12.2013 31.12.2014 31.12.2015 31.12.2016 31.12.2017 31.12.2018 31.12.2019 31.12.2020 31.12.2021
PepsiCo Inc 19.23% 18.93% 19.58% 19.72% 20.71% 20.18% 20.73% 21.28% 22.39%
Colgate-Palmolive Co 26.17% 26.89% 27.62% 29.08% 28.38% 28.61% 29.08% 28.64% 29.58%
General Mills Inc 19.52% 19.39% 20.20% 21.83% 21.83% 20.66% 21.04% 21.42% 23.67%
Kraft Heinz Co 6.89% 19.21% 18.43% 32.17% 31.70% 29.76% 30.24% 30.14% 31.49%
Coca-Cola Co 28.20% 27.12% 27.49% 27.35% 30.31% 35.74% 36.79% 37.79% 38.87%
Nestle SA 19.88% 18.74% 19.18% 19.44% 20.08% 20.13% 20.77% 21.92% 21.95%
Danone SA 13.28% 14.66% 16.50% 17.19% 17.17% 18.73% 19.28% 19.67% 20.73%
Henkel AG & Co KgaA 17.93% 18.47% 18.59% 19.96% 20.80% 20.39% 20.67% 21.15% 21.38%
L'Oreal SA 20.71% 21.05% 21.85% 22.45% 22.45% 22.58% 22.78% 23.07% 22.86%
Reckitt Benckiser Group PLC 24.80% 26.55% 28.78% 30.20% 29.10% 28.88% 29.45% 30.06% 30.80%
Beiersdorf AG 15.40% 16.63% 16.27% 17.73% 17.66% 17.92% 18.39% 18.98% 19.22%
Procter & Gamble Co 22.92% 24.26% 26.71% 26.91% 26.91% 25.99% 26.31% 26.27% 28.12%
Unilever NV 17.14% 18.61% 16.45% 16.85% 18.57% 19.00% 20.00% 20.50% 21.50%
Min 6.89% 14.66% 16.27% 17.19% 17.17% 17.92% 18.39% 18.98% 19.22%
0.25 17.30% 18.68% 18.55% 19.65% 20.55% 20.17% 20.71% 21.24% 21.81%
Peer Group 6.09% 6.16% 8.36% 8.13% 8.01% 8.50% 8.46% 7.75% 8.07%
Median 19.70% 19.30% 19.89% 22.14% 22.14% 21.62% 21.91% 22.49% 23.26%
0.75 23.39% 24.83% 26.90% 27.78% 28.56% 28.67% 29.17% 29.00% 29.88%
Max 28.20% 27.12% 28.78% 32.17% 31.70% 35.74% 36.79% 37.79% 38.87%
22
Equity Research 14.06.2018
Henkel AG & Co. KGaA 2.4x 2.3x 2.2x 13.5x 13.7x 14.2x 16.2x 16.4x 16.5x 19.0x 17.8x 16.8x
L'Oréal S.A. 4.0x 3.9x 3.7x 17.2x 17.0x 17.5x 22.2x 21.3x 20.0x 27.6x 26.2x 24.6x
Reckitt Benckiser Group
plc 5.5x 4.8x 4.7x 17.0x 15.7x 15.5x 20.2x 17.8x 16.7x 21.2x 19.4x 18.0x
Beiersdorf
Aktiengesellschaft 2.9x 2.8x 2.7x 16.3x 14.6x 14.6x 18.6x 17.6x 16.3x 29.3x 27.4x 25.3x
The Procter & Gamble
Company 3.1x 3.8x 3.7x 13.4x 12.5x 13.0x 14.5x 17.0x 16.1x 19.6x 22.0x 20.6x
The Kraft Heinz
Company 4.8x 4.7x 4.6x 15.5x 13.5x 13.3x 16.9x 16.0x 15.3x 21.6x 20.0x 19.0x
The Coca-Cola
Company 6.2x 6.6x 6.3x 20.0x 18.5x 17.8x 28.6x 20.5x 19.0x 21.7x 20.1x 18.7x
PepsiCo, Inc. 2.5x 2.5x 2.4x 13.3x 11.6x 11.4x 15.4x 15.0x 13.8x 18.7x 17.2x 16.0x
Colgate-Palmolive
Company 3.9x 3.7x 3.6x 13.5x 12.5x 12.4x 15.2x 15.1x 13.8x 21.7x 19.7x 18.2x
General Mills, Inc.
2.3x 2.2x 2.1x 13.0x 13.8x 14.5x 15.2x 15.6x 16.2x 14.0x 13.9x 13.4x
23
Equity Research 14.06.2018
DCF 2012 2013 2014 2015 2016 2017 CAGR 2018 2019 2020 2021 2022 TV
Revenue 51,324 49,797 48,436 53,272 52,713 53,715 0.9% 54,789 56,433 58,126 60,451 62,869
COGS (30,530) (29,065) (28,387) (30,808) (30,229) (30,547) (0.0%) (30,682) (31,320) (31,969) (32,946) (33,949)
Gross Profit 20,794 20,732 20,049 22,464 22,484 23,168 2.2% 24,107 25,113 26,157 27,505 28,920
SG&A (12,959) (12,308) (11,208) (14,065) (13,799) (13,507) (0.8%) (13,697) (13,826) (14,241) (14,508) (14,774)
R & D expenses (1,003) (1,040) (955) (1,005) (978) (900) 2.1% (1,096) (1,129) (1,163) (1,209) (1,257)
Other Operating
Costs (13,962) (13,348) (12,163) (15,070) (14,777) (14,407) (0.6%) (14,793) (14,955) (15,403) (15,717) (16,032)
EBIT 6,832 7,384 7,886 7,394 7,707 8,761 5.1% 9,314 10,158 10,753 11,788 12,888
Taxes (1,738) (1,879) (2,007) (1,881) (1,961) (2,229) (5.1%) (2,370) (2,585) (2,736) (3,000) (3,280)
NOPLAT 5,094 5,505 5,879 5,513 5,746 6,532 5.1% 6,944 7,573 8,017 8,788 9,609
Plus: D&A 1,199 1,151 1,127 1,370 1,173 1,214 0.2% 1,096 1,129 1,163 1,209 1,257
Plus/Less: Changing
Working Cap 146 861 267 434 (1,955) (266) 125 128 186 192
Less: CAPEX (1,975) (1,791) (1,893) (1,867) (1,804) (1,509) 5.2% (1,534) (1,580) (1,628) (1,693) (1,760)
CAPEX (1,975) (1,791) (1,893) (1,867) (1,804) (1,509) 5.2% (1,534) (1,580) (1,628) (1,693) (1,760)
Unlevered Free
Cash Flow 4,318 5,011 5,974 5,283 5,549 4,282 (0.2%) 6,240 7,247 7,680 8,490 9,297 184,443
24
Equity Research 14.06.2018
Enterprise Value Implied Equity Value and Share Price Implied Perpetuity Growth Rate
Enterprise Value
Cumulative Sum of PV 32,371 PGM Terminal Year FCF 9,297
Enterprise Value
EEM WACC 6.1%
Perpetuity Growth Method (PGM) Less: Net Debt Terminal Value 184,443
Discount Factor 0.74 Less. Non-Controlling Interest Implied Perp. Growth Rate 1.00%
Terminal Value Exit Multiple Method 192,379 as of 31.12.2017 EBITDA 2018 10,410
Enterprise Value EEM 175,512 Implied Share Price PGM Peer Group EV / EBITDA (x) 13.6x
Current Share
Date Price
01/01/201
Starting 8 Return Potential % (PGM)
31/05/201
End of Valuation 8 Return Potential % (EEM)
25
Equity Research 14.06.2018
WACC & g
26
Equity Research 14.06.2018
Terminal Value
Cost of equity 6.81%
Scenario 1 20%
Mil. Shares Outst. 2,814
Scenario 2 25%
Scenario 3 29% Dividend 2017 1.43
g (Terminal
Scenario Dividend 2017 Growth (2-10) Growth (11-20) Value) Share Price Weighting
Scenario 1 Scenario 2
6.00 10.00
5.00 8.00
4.00
6.00
3.00
4.00
2.00
1.00 2.00
0.00 0.00
2018
2020
2022
2024
2026
2028
2030
2032
2034
2036
2018
2020
2022
2024
2026
2028
2030
2032
2034
2036
Scenario 3
15.00
10.00
5.00
0.00
2018
2020
2022
2024
2026
2028
2030
2032
2034
2036
27
Equity Research 14.06.2018 <Consumer Goods>
28
Equity Research 14.06.2018
29
Equity Research 14.06.2018 <Consumer Goods>
Disclaimer:
Disclosures:
Receipt of compensation: Compensation of the author(s) of this report is not based on revenue.
Position as a officer or director: The author(s), or a member of their household, does not serve as
an officer, director or advisory board member of the subject company.
Market making: The author(s) does not act as a market maker in the subject company’s
securities.
Disclaimer: The information set forth herein has been obtained or derived from sources generally
available to the public and believed by the author(s) to be reliable, but the author(s) does not
make any representation or warranty, express or implied, as to its accuracy or completeness. The
information is not intended to be used as the basis of any investment decisions by any person or
entity. This information does not constitute investment advice, nor is it an offer or a solicitation of
an offer to buy or sell any security. This report should not be considered to be a recommendation
by any individual affiliated with WUTIS – Trading and Investment Society
30
Unilever N.V.
Target Price: € 52.07
Current Price: 47.74 as of 31th May
Upside: 9.1 %
Recommendation: BUY
Investment Horizon: 6 Months
Vienna, 15th of June
2 Business Description 5
4 Financial Analysis 13
5 Valuation Analysis 17
6 Risk Analysis 19
7 Appendix 22
Industry
Industry&&growth
growthpotential
potential Business
Business
model
model Unilever’s 1-year share price history
54 €
EUR 52.07
52 €
50 €
Limited
Limited Highly
Highly diversified
diversified
market risk
market risk business model
business model 48 €
EUR 47.74
6 6 1 1
46 €
55 2 2 44 €
One One of biggest
of the the biggest
Tata
TataSteel
Steelmerger
merger producer
producer of of
Below
Below industry
industry consumer goods 42 €
creates
createssteel
steelgiant
giant consumer goods
valuation
valuation
4 4 3 3
40 €
06/2017 08/2017 10/2017 12/2017 02/2018 04/2018 06/2018
Growth
Growthpotential
potential
MoreMore
than than
400 400 Upside
brands
brands
worldwide
worldwide Trading Price: Target Price:
Potential:
EUR 47.74 EUR 52.07
9.1%
• UN operates in the Fast Moving Consumer Goods (FMCG) Industry • 2015 Acquisition of Kate Somerville
making and selling around 400 brands in more than 190 countries, • 2015 Acquisition of Dermalogica
giving Unilever a unique position in emerging markets where • 2016 Acquisition of Dollar Shave Club
58% of the turnover is generated.
• 2017 Carver Korea
• Unilever operates and manages 306 factories in 69 countries and • 2017 Block Chain collaboration with IBM
maintains a network of approximately 400 warehouses in various • 2017 Agreement signed with Alibaba-backed Lazada
markets. • 2018 Acquisition of Quala”s beauty & personal a
• Unilever is organized into four main divisions: the largest being • 2018 Beginning of a program to buy back shares with an
Personal Care (39% of Turnover), followed by Foods (23%), Home aggregate market value of up to €6 biillion.
Care (20%) and Refreshment (18%).
Ratios & Key Indicators 2012 2013 2014 2015 2016 2017
In % of revenue
Revenue 51,324 49,797 48,436 53,272 52,713 53,715
EBITDA % 16% 17% 19% 16% 17% 19%
EBIT % 13% 15% 16% 14% 15% 16%
Liquidity KPIs
Current Ratio (x) 0.8 0.7 0.6 0.6 0.7 0.7
Net Working Capital (WC) -5,824 -5,970 -6,831 -7,098 -7,532 -5,577
Profitability Ratios
Gross Profit margin % 41% 42% 41% 42% 43% 43%
Operating Profit margin % 13% 15% 16% 14% 15% 16%
ROE % 31% 36% 32% 31% 39%
Financial Ratios
Total Debt / Equity (x) 0.9 1.0 1.,2 1.2 1.3 2.0
Equity Ratio % 33% 32% 28% 30% 29% 23%
14,000 6,000
10% 10%
12,000
5% 4,000 5%
10,000
8,000 0% 2,000 0%
2012 2013 2014 2015 2016 2017 2012 2013 2014 2015 2016 2017
10,000
5.0% 4,000 5%
SHAREHOLDERS
CEO – Paul Polman
• Change the strategy moving from the Foods segment to the TICKER: UNA TICKER: ULVR
TRADED: 1 UNA = 1 ULVR TRADED:
Personal Care segment AMSTERDAM LONDON
d’Honneur
TICKER: UN TICKER: UL
TRADED: 1 UN = 1 UL TRADED:
NYSE NYSE
$ billion % Growth
© Equity Research - 10 - | Valid until 30/06/2018 WUTIS.
Home Care Segment
Driven by change in demographics and hygiene habits
12% Growth of demand for soap and cleansers, APAC Five largest Home Care product consumers. In
region million EUR
10% 7%
5% 39%
12%
2%
-1%
-3%
31%
• Continuously rise in Total Debt with spike in 2017 • Substantial variation in revenues
• 8 bn. EUR increase mainly by issuing bonds • Gains in 2017 ensured new revenue record for
Unilever
• 5 bn. EUR repurchase of shares in 2017 • Revenues consistently above 50 bn. EUR hurdle
• Unique action • High exposure to currency fluctuation
• Revenues typically move with exchange rates
• Low avg. after tax cost of debt 1.57% effect
Assumptions:
• Revenues growing at average 3%
DCF
• EBIT margin will reach 18,5% by 2020
• Consistently returning cash to its shareholders for almost
DDM 20 years and showed an average of 8% YoY growth
• DDM price EUR 50.84 and Multiples price EUR 54.17
P/E LTM
EV/EBIT Y1
180,000 1000
169,607
EV/EBIT
LTM 160,000 800
+4,009
145,630
EV/EBITDA 140,000 -758 600
LTM -27,228 Dil. Shares
2,814 Mil
120,000 400
EV/Rev Y1
100,000 200
EV/Rev LTM
52,07
80,000 0
€ 30.00 € 40.00 € 50.00 € 60.00 € 70.00 € 80.00 € 90.00 EV Total Debt Cash and Minority Equity Value Share Price
Cash equiv. Interest
Investment risks:
Ethical Branding
The firm, along with some competitors
(Nestlé), is under public scrutiny for it´s
operations in underdeveloped areas.
Mitigation: Ethical Guidelines and Publicity
Total Cash & ST Investments 3,232.0 3,239.0 2,771.0 3,022.0 4,128.0 4,009.0
Curr. Port. of Cap. Leases 15.0 14.0 13.0 37.0 9.0 11.0
Curr. Income Taxes Payable 1,129.0 1,254.0 1,081.0 1,127.0 844.0 1,088.0
Pension & Other Post-Retire. Benefits 4,100.0 2,968.0 3,947.0 3,254.0 3,867.0 2,734.0
Def. Tax Liability, Non-Curr. 1,414.0 1,524.0 1,534.0 1,744.0 2,061.0 1,913.0
Comprehensive Inc. and Other (2,194.0) (2,856.0) (3,413.0) (3,697.0) (3,279.0) (4,425.0)
Total Liabilities And Equity 46,189.0 45,513.0 48,027.0 52,298.0 56,429.0 60,285.0
LIABILITIES
Accounts Payable 15.34% 15.37% 15.90% 15.86% 15.22% 13.63%
Accrued Exp. 8.40% 8.57% 7.76% 7.98% 7.31% 6.98%
Short-term Borrowings 2.33% 5.56% 6.74% 6.23% 5.79% 10.65%
Curr. Port. of LT Debt 3.39% 3.22% 4.76% 2.86% 3.85% 2.55%
Curr. Port. of Cap. Leases 0.03% 0.03% 0.03% 0.07% 0.02% 0.02%
Curr. Income Taxes Payable 2.44% 2.76% 2.25% 2.15% 1.50% 1.80%
Other Current Liabilities 2.31% 2.69% 3.46% 3.12% 2.74% 2.82%
Total Current Liabilities 34.24% 38.19% 40.90% 38.28% 36.43% 38.45%
Long-Term Debt 15.97% 16.04% 14.58% 18.54% 19.51% 27.11%
Capital Leases 0.40% 0.42% 0.39% 0.30% 0.24% 0.20%
Pension & Other Post-Retire. Benefits 8.88% 6.52% 8.22% 6.22% 6.85% 4.54%
Def. Tax Liability, Non-Curr. 3.06% 3.35% 3.19% 3.33% 3.65% 3.17%
Other Non-Current Liabilities 2.91% 2.93% 3.03% 2.57% 3.23% 2.67%
Total Liabilities 65.47% 67.45% 70.30% 69.25% 69.91% 76.14%
Common Stock 1.05% 1.06% 1.01% 0.93% 0.86% 0.80%
Additional Paid In Capital 0.30% 0.30% 0.30% 0.29% 0.24% 0.22%
Retained Earnings 45.39% 44.97% 42.81% 43.25% 41.08% 44.20%
Treasury Stock -8.66% -8.55% -8.59% -7.88% -7.38% -15.27%
Comprehensive Inc. and Other -4.75% -6.28% -7.11% -7.07% -5.81% -7.34%
Total Common Equity 33.32% 31.52% 28.42% 29.52% 28.98% 22.61%
Minority Interest 1.21% 1.03% 1.27% 1.23% 1.11% 1.26%
Total Equity 34.53% 32.55% 29.70% 30.75% 30.09% 23.86%
Total Liabilities And Equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Income Statement
2012 2013 2014 2015 2016 2017
Revenue 51,324.0 49,797.0 48,436.0 53,272.0 52,713.0 53,715.0
Total Revenue 51,324.0 49,797.0 48,436.0 53,272.0 52,713.0 53,715.0
Cost Of Goods Sold 30,530.0 29,065.0 28,387.0 30,808.0 30,229.0 30,547.0
Gross Profit 20,794.0 20,732.0 20,049.0 22,464.0 22,484.0 23,168.0
Selling General & Admin Exp. 12,959.0 12,308.0 11,208.0 14,065.0 13,799.0 13,507.0
R & D Exp. 1,003.0 1,040.0 955.0 1,005.0 978.0 900.0
Other Operating Exp., Total 13,962.0 13,348.0 12,163.0 15,070.0 14,777.0 14,407.0
Operating Income 6,832.0 7,384.0 7,886.0 7,394.0 7,707.0 8,761.0
Interest Expense (524.0) (497.0) (486.0) (552.0) (572.0) (608.0)
Interest and Invest. Income 136.0 117.0 162.0 235.0 219.0 175.0
Net Interest Exp. (388.0) (380.0) (324.0) (317.0) (353.0) (433.0)
Income/(Loss) from Affiliates 105.0 113.0 98.0 107.0 127.0 155.0
Currency Exchange Gains (Loss) (2.0) (3.0) (14.0) 36.0 (12.0) 13.0
Other Non-Operating Inc. (Exp.) - - - - - (26.0)
EBT Excl. Unusual Items 6,547.0 7,114.0 7,646.0 7,220.0 7,469.0 8,470.0
Gain (Loss) On Sale Of Invest. (14.0) - - - - -
Legal Settlements - - - - - 65.0
Other Unusual Items - - - - - (382.0)
EBT Incl. Unusual Items 6,533.0 7,114.0 7,646.0 7,220.0 7,469.0 8,153.0
Income Tax Expense 1,697.0 1,851.0 2,131.0 1,961.0 1,922.0 1,667.0
Net Income to Company 4,836.0 5,263.0 5,515.0 5,259.0 5,547.0 6,486.0
Minority Int. in Earnings (468.0) (421.0) (344.0) (350.0) (363.0) (433.0)
Net Income 4,368.0 4,842.0 5,171.0 4,909.0 5,184.0 6,053.0
DCF 2012 2013 2014 2015 2016 2017 CAGR 2018 2019 2020 2021 2022 TV
Revenue 51,324 49,797 48,436 53,272 52,713 53,715 0.9% 54,789 56,433 58,126 60,451 62,869
COGS (30,530) (29,065) (28,387) (30,808) (30,229) (30,547) (0.0%) (30,682) (31,320) (31,969) (32,946) (33,949)
Gross Profit 20,794 20,732 20,049 22,464 22,484 23,168 2.2% 24,107 25,113 26,157 27,505 28,920
SG&A (12,959) (12,308) (11,208) (14,065) (13,799) (13,507) (0.8%) (13,697) (13,826) (14,241) (14,508) (14,774)
R & D expenses (1,003) (1,040) (955) (1,005) (978) (900) 2.1% (1,096) (1,129) (1,163) (1,209) (1,257)
Other Operating Costs (13,962) (13,348) (12,163) (15,070) (14,777) (14,407) (0.6%) (14,793) (14,955) (15,403) (15,717) (16,032)
EBIT 6,832 7,384 7,886 7,394 7,707 8,761 5.1% 9,314 10,158 10,753 11,788 12,888
Taxes (1,738) (1,879) (2,007) (1,881) (1,961) (2,229) (5.1%) (2,370) (2,585) (2,736) (3,000) (3,280)
NOPLAT 5,094 5,505 5,879 5,513 5,746 6,532 5.1% 6,944 7,573 8,017 8,788 9,609
Plus: D&A 1,199 1,151 1,127 1,370 1,173 1,214 0.2% 1,096 1,129 1,163 1,209 1,257
Plus/Less: Changing
Working Cap 146 861 267 434 (1,955) (266) 125 128 186 192
Less: CAPEX (1,975) (1,791) (1,893) (1,867) (1,804) (1,509) 5.2% (1,534) (1,580) (1,628) (1,693) (1,760)
CAPEX (1,975) (1,791) (1,893) (1,867) (1,804) (1,509) 5.2% (1,534) (1,580) (1,628) (1,693) (1,760)
Unlevered Free Cash
(0.2%)
Flow 4,318 5,011 5,974 5,283 5,549 4,282 6,240 7,247 7,680 8,490 9,297 184,443
Cost of Equity
2-Y relevered Beta 0.68 Bottom-Up Approach Market risk premium 6.8%
2-Y relevered Beta 0.68
Cost of Equity 6.81%
Cost of Equity 6.81%
Henkel AG & Co. KGaA 2.4x 2.3x 2.2x 13.5x 13.7x 14.2x 16.2x 16.4x 16.5x 19.0x 17.8x 16.8x
L'Oréal S.A. 4.0x 3.9x 3.7x 17.2x 17.0x 17.5x 22.2x 21.3x 20.0x 27.6x 26.2x 24.6x
Reckitt Benckiser Group plc 5.5x 4.8x 4.7x 17.0x 15.7x 15.5x 20.2x 17.8x 16.7x 21.2x 19.4x 18.0x
Beiersdorf
Aktiengesellschaft 2.9x 2.8x 2.7x 16.3x 14.6x 14.6x 18.6x 17.6x 16.3x 29.3x 27.4x 25.3x
The Procter & Gamble
Company 3.1x 3.8x 3.7x 13.4x 12.5x 13.0x 14.5x 17.0x 16.1x 19.6x 22.0x 20.6x
The Kraft Heinz Company 4.8x 4.7x 4.6x 15.5x 13.5x 13.3x 16.9x 16.0x 15.3x 21.6x 20.0x 19.0x
The Coca-Cola Company 6.2x 6.6x 6.3x 20.0x 18.5x 17.8x 28.6x 20.5x 19.0x 21.7x 20.1x 18.7x
PepsiCo, Inc. 2.5x 2.5x 2.4x 13.3x 11.6x 11.4x 15.4x 15.0x 13.8x 18.7x 17.2x 16.0x
Colgate-Palmolive Company 3.9x 3.7x 3.6x 13.5x 12.5x 12.4x 15.2x 15.1x 13.8x 21.7x 19.7x 18.2x
General Mills, Inc.
2.3x 2.2x 2.1x 13.0x 13.8x 14.5x 15.2x 15.6x 16.2x 14.0x 13.9x 13.4x
2020
2022
2024
2026
2028
2030
2032
2034
2036
2018
2020
2022
2024
2026
2028
2030
2032
2034
2036
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
50.98 1.23 1.33 1.43 1.53 1.63
5.8% 53.27 57.56 61.85 66.15 70.44
6.3% 48.13 52.01 55.88 59.76 63.63
6.8% 43.92 47.45 50.98 54.51 58.05
7.3% 40.38 43.62 46.87 50.11 53.36
7.8% 37.36 40.36 43.35 46.35 49.35
90
83 70 68 69
66 66 66 65
80 62 63
59
70 71 60 58
70
64
60 56 50
53
51 41 41 41 41
50 40
40
39
40
30
30
20
20
10 10
0
Large: Revenues > 1 Medium: 500 mio EUR < Small: Revenues < 500 0
bn. EUR Revenues < 1 bn. EUR mio. EUR 2012 2013 2014 2015 2016
Mr. Graeme Pitkethly has been the Chief Financial Officer of the company since October 2015. He was appointed as a
Director of the company in April 2016. Previously, Mr. Pitkethly held several leadership roles including Executive Vice
President and Chairman for Unilever UK and Ireland, Senior Vice President of Finance for Global Markets, Global Head of
Mergers and Acquisitions, Head of Treasury, Pensions and Tax, and Chief Financial Officer of Unilever Indonesia. Prior to
joining the company, he held several senior corporate finance roles at PricewaterhouseCoopers and in the
telecommunications industry.
Mr. Paul Polman has been the Chief Executive Officer and Director of the company since January 2009. He was appointed as
an Executive Director of the company in October 2008. Prior to this, Mr. Polman served as the Chief Financial Officer of Nestle
S.A. from January 2006 and as the Executive Vice President for the Americas from February 2008. He began his career at
Procter & Gamble in 1979 and served as Group President Europe and Officer until 2001. He also serves as a Director of The
Consumer Goods Forum.
David Blanchard Senior Management Chief Research and Development Officer 2014
Mr. David Blanchard has been the Chief Research and Development Officer of the company since April 2014. Previously, he
served as the Chief Category Research and Development Officer of the company since January 2013. Mr. Blanchard joined
the company in 1986 as the Development Manager of Spreads and held several senior managerial positions including Senior
Vice President of Unilever Research and Development, Senior Vice President of Marketing Operations Foods Americas, Vice
President of Research and Development for Global Dressing and the Chairman of Unilever Canada Inc.
Mr. Keith Weed has been the Chief Marketing and Communications Officer of the company since April 2010. He joined the
company in 1983 and held various managerial positions such as Executive Vice President for Global Home Care and Hygiene
and the Chairman of Lever Faberg
Mr. Marc Engel has been the Chief Supply Chain Officer of the company since January 2016. Previously, he held several
leadership roles at the company, including the Executive Vice President of Unilever East Africa and Emerging Markets; Chief
Procurement Officer and Vice President for Supply Chain, Spreads, Dressings and Olive Oil Europe at Unilever Supply Chain
Company. Mr. Engel also served as the Operations Manager for Birds Eye Wall’s at Unilever UK; and Unilever Meat Group
NL.
Ms. Ritva Sotamaa has been the Chief Legal Officer of the company since February 2013. Previously, she served as the
General Counsel for Siemens AG – Siemens Healthcare. Ms. Sotamaa also held several managerial roles at General Electric
Company including General Counsel, GE Healthcare Systems and General Counsel at Instrumentarium Corporation.
Mr. Marijn Dekkers has been the Non-Executive Chairman of the company since April 2016. Previously, he served as Chief
Executive Officer at Bayer AG and Thermo Fisher Scientific Inc. Currently, Mr. Dekkers serves as the Non Executive Director
at General Electric.
19-Mar-18 Colgate gains as much as 2%, Estee Lauder as much as 1% after The Times of the U.K. reported the Unilever is preparing for 0.3586%
"a series of blockbuster mergers that could include deals with rivals such as Colgate-Palmolive and Estée Lauder"
01-Feb-18 Unilever Fourth Quarter Underlying Sales Beat Estimates 0.7288%
30-Jan-18 Unilever Ghana Full Year Revenue 575.3 Mln Cedis 0.7058%
27-Oct-17 Unilever Ghana Nine Months Revenue 428.2 Mln Cedis 0.7062%
26-Oct-17 Hindustan Unilever Second Quarter Net Income Beats Estimates 3.4300%
25-Oct-17 Hindustan Unilever Second Quarter Net Income Beats Estimates -0.3166%
20-Oct-17 -2.8659%
Unilever shares drop as much as 1.9%, extending Thursday’s losses after 3Q adj. sales growth missed estimates
19-Oct-17 Unilever’s poor performance in 3Q came in below expectations in all geographies -5.8373%
26-Sep-17 Korean Cosmetics Stocks Rise After Unilever-Carver $2.7b Deal 0.1619%
20-Jul-17 Unilever First Half Revenue Misses Estimates 0.3520%
o Innovation pipeline o Palm oil scandal (2017) o From Plc and N.V. to New
o WCM sites o Transparency campaign N.V.
o Digital transformation in (2018) o Complexity associated with
Supply chain (saving 4bn) o Reducing environmental taxation under different
impact across the entire jurisdictions
production
12%
10%
8%
6%
4%
• Speed 2%
Digital
Transformation • Agility 0%
Black Tea Tomatoes Palm Oil
• Cost reduction
Strengths Weaknesses
• Global presences – sales +190 countries • Dependence on Distribution and Retailers
• Brand product mix – strong popular brands – lack of forward integration
• Focused R&D activities and integrated • High number of substitutes
supply chain • Limited business diversification
• Economies of scale
• Evolving Portfolio and Developing
Channels
SWOT
Opportunities Threats
• Potential in Emerging Markets
• Growing Demand for Premium and • Global and regional Competitors
Specialized High-End products in Skin • Private label brands from Retailers
Care Segment • Product imitation
• Social Media for advertising • An increase of social ethic and concern
for the environment among customers
• Stricter regulations
Buyer
Competitor Rivalry: There are not only small or reginal shops but
Power also big giants like P&G, Kraft and Nestle. These big industries
5 have the power to persuade the customer by introducing the
4 equally attractive and best performer products. Low switching cost
allow customer to switch to other brands easily.
3
2 Barriers Threat of Substitutes: Today consumers like to try something
Rivalry
to entry
1 new and better at least once reducing customer devotion and
0 willing to go for the same usable products which substitutes from
Unilever.
This document is being made available by WUTIS Trading and Investment Society, acting through its investment bank ("WUTIS"), for information purposes only and for the sole and exclusive use of the addressee in
connection with the matter or possible transaction to which this document relates. This document is incomplete without reference to, and should be assessed solely in conjunction with, the oral briefing provided by WUTIS.
This document is strictly confidential and remains the property of WUTIS. You agree that you shall only use this document for the purpose of evaluating and considering the matter or possible transaction to which this
document relates. This document may not be distributed, published, reproduced, or disclosed, in whole or in part, to any other person, nor relied upon by you or any other person, nor used for any other purpose at any time,
in each case without the prior written consent of WUTIS.
This document does not constitute nor does it form part of an offer to sell or purchase, or the solicitation of an offer to s ell or purchase, any securities or any of the businesses or assets described herein or an offer or
recommendation to enter into any transaction described herein nor does this document constitute an offer or commitment to provide, arrange or underwrite any financing. You are responsible for making your own
independent investigation and appraisal of the risks, benefits, appropriateness and suitability of any transaction or matter contemplated by this document and WUTIS is not making any recommendation (personal or
otherwise) or giving any investment advice and will have no liability with respect thereto. The decision to proceed with any transaction or action contemplated by this document must be made by you in the light of your own
commercial assessments and WUTIS will not be responsible for such assessments.
Neither WUTIS nor any of its subsidiaries or affiliates, nor any of their respective officers, directors, employees or agents (WUTIS together with such persons being the “WUTIS Group”) accepts any liability whatsoever for
any direct, indirect or consequential losses (in contract, tort or otherwise) arising from the use of this document or its co ntents or any reliance on the information contained herein. WUTIS Group is not responsible for any
specialist advice, including legal, regulatory, accounting, model accounting, tax, actuarial or other advice.
This document was prepared on the basis of information and data, obtained from publicly available sources and, where applicab le, from you and/or any other entity that may be involved in any transaction or matter
contemplated by this document (and/or any of your or the aforementioned entities’ affiliates), in each case prior to or on the date hereof. The information in this document has not been independently verified by WUTIS.
WUTIS has relied on any information provided by you or from third party or public sources as complete, true, fair, accurate and not misleading. With respect to any financial or operating forecasts and analyses provided to
it, WUTIS has assumed that they are achievable and have been reasonably and properly prepared on bases reflecting the best cu rrently available information, estimates and judgments as to the future financial performance
of the entity(ies) to which they relate and that such forecasts or analyses would be realised in the amounts and time periods contemplated thereby. No member of the WUTIS Group, makes any warranty or representation,
express or implied, as to the accuracy, completeness or reasonableness of the information (including projections and assumptions) contained in this document whether obtained from or based upon third party or public
sources or otherwise.
This document is given as at the date hereof, may not be final, is based on information available to WUTIS as at the date her eof, is subject to any assumptions set out therein and is subject to change without notice.
Accordingly, this document may be based on (a) data and information that may no longer be current and (b) estimates that may involve highly subjective assessments. It should be understood that subsequent
developments may affect this document and the WUTIS Group does not undertake any obligation to provide any additional information or to update any of the information or the conclusions contained herein or to correct
any inaccuracies which may become apparent. Any data or information regarding, or based on, past performance is no indication of future performance.
Members of the WUTIS Group are involved in a wide range of commercial banking, investment banking and other activities out of which conflicting interests or duties may arise. In the ordinary course of its business, the
WUTIS Group may provide services to any other entity or person whether or not a member of the same group as you (a “Third Party”), engage in any transaction (whether on its own account, on behalf of any Third Party or
otherwise, and including any transaction or matter contemplated by this document), notwithstanding that such services, transactions or actions may be adverse to you or any member of your group, and the WUTIS Group
may retain for its own benefit any related remuneration or profit. The WUTIS Group operates in accordance with a conflicts of interest policy which identifies conflicts of interest it faces in the ordinary course of its business,
and establishes organisational and procedural measures to manage those conflicts where it is reasonably able to do so. Neithe r WUTIS nor any other part of the WUTIS Group shall have any duty to disclose to you or
utilise for your benefit any non-public information acquired in the course of providing services to any other person, engaging in any transaction (on its own account or otherwise) or otherwise carrying on its business.
WUTIS’ research analysts and research departments are independent from its investment bank and are subject to certain regulations and internal policies. WUTIS research analysts may hold opinions and make statements
or investment recommendations and/or publish research reports with respect to any company referred to herein, the transactions contemplated herein or any person or entity involved therein or related thereto that differ
from or are inconsistent with the views or advice communicated by WUTIS’ investment bank. WUTIS is a full service securities firm and as such from time to time may effect transactions for its own account or the account
of its clients and hold long or short positions in debt, equity or other securities of the companies referred to herein.
WUTIS Bank PLC is authorised and regulated in the United Kingdom by the Financial Services Authority and is registered in England No. 1026167. Registered Office: 1 Churchill Place, London E14 5HP. Copyright WUTIS
Bank PLC.